<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="453">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02092441</url>
  </required_header>
  <id_info>
    <org_study_id>BAMC 395266-1</org_study_id>
    <nct_id>NCT02092441</nct_id>
  </id_info>
  <brief_title>Inhalation Intervention for Nausea in the Emergency Department</brief_title>
  <official_title>Inhalation Intervention for Nausea in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brooke Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brooke Army Medical Center</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial comparing inhalation of isopropyl alcohol vs placebo (normal
      saline) pads to treat nausea in emergency department patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is to investigate if inhaling the scent of a typical medical alcohol prep pad
      will alleviate nausea as compared to a identically packaged normal saline prep pad for the
      Emergency Department patient with nausea. The study length will be 10 minutes long. The
      subjects will take several deep nasal inhalations at the 0, 2, 5 minute marks. Level of
      nausea will be recorded during these times and at 10 minutes. The investigators will also
      assess satisfaction of the intervention. As in previous post operative unit studies,the
      hypothesis is that there will a significant difference in levels of nausea between the
      alcohol pad group versus the normal saline pad group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Significant Change in Level of Nausea at 4 Minutes Post Intervention</measure>
    <time_frame>4 minutes post intervention</time_frame>
    <safety_issue>No</safety_issue>
    <description>Primary outcome is significant change of nausea and vomiting is defined decrease of 3 on a 0-10 Verbal Numerical Response Scale (VNRS) compared with initial score prior to intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Effect for Significant Change in Nausea Level</measure>
    <time_frame>Initial assessment, 2 minute, 5 minute, and 10 minute</time_frame>
    <safety_issue>No</safety_issue>
    <description>Secondary outcomes are time to effect, and satisfaction of intervention.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Secondary Outcome of Satisfaction.</measure>
    <time_frame>2 minute, 5 minute, and 10 minute</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient satisfaction of smelling prep pad to alleviate nausea.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Nausea</condition>
  <condition>Vomiting</condition>
  <arm_group>
    <arm_group_label>Alcohol prep pad group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>isopropyl alcohol prep pad</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline prep pad</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline prep pad</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Alcohol prep pad group</intervention_name>
    <description>Subjects inhale scent of alcohol pad</description>
    <arm_group_label>Alcohol prep pad group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline prep pad</intervention_name>
    <description>Subjects inhale scent of placebo (normal saline) pads</description>
    <arm_group_label>Normal Saline prep pad</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age range of 18-65 years of age

          -  complaint of nausea and or vomiting

          -  ability to breathe through nose

          -  ability to read and write English

        Exclusion Criteria:

          -  allergy to isopropyl alcohol

          -  pregnancy or pregnancy status unknown to subject. Pregnancy test only if part of
             clinical course.

          -  recent upper respiratory infection

          -  recent intake of cefoperazone, disulfiram, or metronidazole or any other medications
             that are known produce nausea when exposed to alcohol.

          -  use of antiemetic or psychoactive drug within 24 hours

          -  alcohol abuse

          -  nicotine within last 4 hrs
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth L Beadle, MPAS, BS</last_name>
    <role>Principal Investigator</role>
    <affiliation>BAMC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Curtis J Hunter, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>BAMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emergency Department, Brooke Army Medical Center</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Burleigh-Flayer HD, Gill MW, Strother DE, Masten LW, McKee RH, Tyler TR, Gardiner T. Isopropanol 13-week vapor inhalation study in rats and mice with neurotoxicity evaluation in rats. Fundam Appl Toxicol. 1994 Oct;23(3):421-8.</citation>
    <PMID>7835543</PMID>
  </reference>
  <reference>
    <citation>Gill MW, Burleigh-Flayer HD, Strother DE, Masten LW, McKee RH, Tyler TR, Gardiner TH. Isopropanol: acute vapor inhalation neurotoxicity study in rats. J Appl Toxicol. 1995 Mar-Apr;15(2):77-84.</citation>
    <PMID>7782562</PMID>
  </reference>
  <reference>
    <citation>Burleigh-Flayer H, Garman R, Neptun D, Bevan C, Gardiner T, Kapp R, Tyler T, Wright G. Isopropanol vapor inhalation oncogenicity study in Fischer 344 rats and CD-1 mice. Fundam Appl Toxicol. 1997 Apr;36(2):95-111.</citation>
    <PMID>9143479</PMID>
  </reference>
  <reference>
    <citation>Cotton JW, Rowell LR, Hood RR, Pellegrini JE. A comparative analysis of isopropyl alcohol and ondansetron in the treatment of postoperative nausea and vomiting from the hospital setting to the home. AANA J. 2007 Feb;75(1):21-6.</citation>
    <PMID>17304779</PMID>
  </reference>
  <reference>
    <citation>Winston AW, Rinehart RS, Riley GP, Vacchiano CA, Pellegrini JE. Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea. AANA J. 2003 Apr;71(2):127-32.</citation>
    <PMID>12776641</PMID>
  </reference>
  <reference>
    <citation>Pellegrini J, DeLoge J, Bennett J, Kelly J. Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV. AANA J. 2009 Aug;77(4):293-9.</citation>
    <PMID>19731848</PMID>
  </reference>
  <reference>
    <citation>Wang SM, Hofstadter MB, Kain ZN. An alternative method to alleviate postoperative nausea and vomiting in children. J Clin Anesth. 1999 May;11(3):231-4.</citation>
    <PMID>10434220</PMID>
  </reference>
  <verification_date>July 2015</verification_date>
  <lastchanged_date>July 3, 2015</lastchanged_date>
  <firstreceived_date>March 18, 2014</firstreceived_date>
  <firstreceived_results_date>July 3, 2015</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brooke Army Medical Center</investigator_affiliation>
    <investigator_full_name>Michael D. April</investigator_full_name>
    <investigator_title>Residency Associate Program Director for Research</investigator_title>
  </responsible_party>
  <keyword>Nausea</keyword>
  <keyword>Vomiting</keyword>
  <keyword>Antiemetic</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nausea</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Alcohol Prep Pad Group</title>
          <description>isopropyl alcohol prep pad
Alcohol prep pad group: Subjects inhale scent of alcohol pad</description>
        </group>
        <group group_id="P2">
          <title>Normal Saline Prep Pad</title>
          <description>normal saline prep pad
Normal Saline prep pad: Subjects inhale scent of placebo (normal saline) pads</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Alcohol Prep Pad Group</title>
          <description>isopropyl alcohol prep pad
Alcohol prep pad group: Subjects inhale scent of alcohol pad</description>
        </group>
        <group group_id="B2">
          <title>Normal Saline Prep Pad</title>
          <description>normal saline prep pad
Normal Saline prep pad: Subjects inhale scent of placebo (normal saline) pads</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="37"/>
                <measurement group_id="B2" value="43"/>
                <measurement group_id="B3" value="80"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="35.65116" spread="14.17557"/>
                <measurement group_id="B2" value="31.94595" spread="12.12652"/>
                <measurement group_id="B3" value="33.9375" spread="13.3154"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="23"/>
                <measurement group_id="B2" value="33"/>
                <measurement group_id="B3" value="56"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
                <measurement group_id="B2" value="10"/>
                <measurement group_id="B3" value="24"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Significant Change in Level of Nausea at 4 Minutes Post Intervention</title>
        <description>Primary outcome is significant change of nausea and vomiting is defined decrease of 3 on a 0-10 Verbal Numerical Response Scale (VNRS) compared with initial score prior to intervention.</description>
        <time_frame>4 minutes post intervention</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Alcohol Prep Pad Group</title>
            <description>isopropyl alcohol prep pad
Alcohol prep pad group: Subjects inhale scent of alcohol pad</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline Prep Pad</title>
            <description>normal saline prep pad
Normal Saline prep pad: Subjects inhale scent of placebo (normal saline) pads</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="37"/>
                  <measurement group_id="O2" value="43"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Significant Change in Level of Nausea at 4 Minutes Post Intervention</title>
            <description>Primary outcome is significant change of nausea and vomiting is defined decrease of 3 on a 0-10 Verbal Numerical Response Scale (VNRS) compared with initial score prior to intervention.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                  <measurement group_id="O2" value="26"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Effect for Significant Change in Nausea Level</title>
        <description>Secondary outcomes are time to effect, and satisfaction of intervention.</description>
        <time_frame>Initial assessment, 2 minute, 5 minute, and 10 minute</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Secondary Outcome of Satisfaction.</title>
        <description>Patient satisfaction of smelling prep pad to alleviate nausea.</description>
        <time_frame>2 minute, 5 minute, and 10 minute</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Alcohol Prep Pad Group</title>
          <description>isopropyl alcohol prep pad
Alcohol prep pad group: Subjects inhale scent of alcohol pad</description>
        </group>
        <group group_id="E2">
          <title>Normal Saline Prep Pad</title>
          <description>normal saline prep pad
Normal Saline prep pad: Subjects inhale scent of placebo (normal saline) pads</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Michael D. April</name_or_title>
      <organization>Brooke Army Medical Center</organization>
      <phone>210-916-6129</phone>
      <email>Michael.D.April@post.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
